55R-79623-42107 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-01-31
Registered in v-safe
2021-01-31
Dose 1 — Moderna
2021-01-31
Health check-in — day 0, dose 1
Feeling: Good · None

Adult check-in
2021-02-01
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Site: Pain · None

Adult check-in
2021-02-02
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-02-03
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2022-01-31
Survey response — 12 months, dose 1
MedDRA: COVID-19, Mechanical urticaria — Feeling: Poor · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation

Free text: I caught Covid post booster and now have a skin condition dermatographic urticaria.

MedDRA releases: 2024-11 · check-in free text available
2022-01-31
Report sent to call center — 12 months, dose 1
Get care from a doctor or other healthcare professional

Telehealth, virtual health, or email health consultation · 1 call case(s)
2022-03-25
Call 1 — Requested Callback
2022-03-30
Call 2 — Left Voicemail

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-01-31	Moderna

Call center

Reported	Outcome	VAERS-related outcome
2022-01-31	Unsuccessful

Free text

Release 11 — 12 months, dose 1

2022-01-31

Symptoms: I caught Covid post booster and now have a skin condition dermatographic urticaria.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	COVID-19	·	·	✓
SD	Mechanical urticaria	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release